In this study, we developed an engineered M1‐like macrophage exosomes expressing IRF5 (IRF5 M1‐exos) and demonstrated their ability to inhibit proliferation, migration, and invasion of lung cancer cells. The gene discussed is IRF5; the disease is lung carcinoma.